Alldna
Microbiome research and data insights for laboratories and research institutions worldwide
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Alldna
allDNA provides microbiome research services, data and insights for laboratories and research institutions worldwide.
The company is based in London and was founded in 2024.
Product: Microbiome research services and data insights for laboratories and research institutions.
Jobs at Alldna
No open positions listed right now.
More biotech & pharma companies
Allergy Therapeutics (UK)
Develops and manufactures allergy immunotherapy treatments and diagnostics for patients and healthcare professionalsNew on EvolcAlturix
Develops and supplies prescription medicines and a bedwetting support app for the NHS and international healthcare marketsNew on EvolcAmaxa
Pharmaceutical company supplying prescription and OTC medicines to specialist markets across Europe, Central Asia and the Middle EastNew on EvolcAmgen
Biotechnology company developing and manufacturing biologic medicines for serious illnesses, with UK sites in Cambridge and UxbridgeNew on EvolcAminoanalytica
AI-enabled, field-ready diagnostics for emerging biological threats, supporting earlier pandemic detection and responseYoung companyNew on EvolcAmo Pharma
Develops investigational treatments for serious diseases, particularly rare genetic disorders, for patients with unmet medical needsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Response headerserver
Frontend frameworks
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.